We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

70 hedge funds and large institutions have $91.9M invested in CapForce IBD 50 ETF in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.93% less ownership

Funds ownership: 28.01%27.08% (-0.93%)

16% less funds holding

Funds holding: 8370 (-13)

21% less capital invested

Capital invested by funds: $116M → $91.9M (-$24.4M)

22% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 27

72% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 18

Holders
70
Holders Change
-13
Holders Change %
-15.66%
% of All Funds
1.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
21
Reduced
27
Closed
18
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
-$518K

FFTY Hedge Fund Activity: Q3 2019 in Review

70 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2019, worth a combined $91.9M — down 21% from $116M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of FFTY and 5 opened new positions — a net loss of 13 holders — while 27 trimmed existing stakes and 21 added.

The largest buyer was UBS Group, adding an estimated $1.59M. The largest seller was Wells Fargo, cutting an estimated $10.2M.

  • 70 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2019, down from 83 in Q2 2019.
  • Funds reported $91.9M of CapForce IBD 50 ETF stock for Q3 2019, down 21% quarter-over-quarter.
  • 5 funds opened new CapForce IBD 50 ETF positions in Q3 2019 and 18 closed out, a net change of -13 holders.
  • The largest CapForce IBD 50 ETF buyer in Q3 2019 was UBS Group, an estimated $1.59M added.
  • The largest CapForce IBD 50 ETF seller in Q3 2019 was Wells Fargo, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2019.